Your position:
m.limatoxi.com
>>
EN
>>
EN
>>
Formulation
>>
India Poised to Become Global Hub for Clinical Trials with Major Investment Plans
>> article
India Poised to Become Global Hub for Clinical Trials with Major Investment Plans
Editor:xuezhe Clicks:
0
Date:2025/2/28 15:54:10
Keyword:
India
Healthoo Information:
UserLogin
UserName：
Password：
The non-formal user may read the summary, the formal user can read the whole article。
please at once register the user of Heatlhoo.com
After registration, we will provide the sample reports and the more comprehensive consulting services for you.
UserName
Contact:
Title:
Mr.
Ms.
Password
Repeat password:
Mobile
Email
Verification code:
Company Name
E-mail:xuezhe@healthoo.com
Tel.:86-10-68012929
Our services:
China Im\Ex data service
Service fees of Chinese Vision
Our service items
Online information introduction
Monthly information
Relative Information
Key events of India PLI plan in pharmaceutical industry in 2024.
Indian Pharmaceutical Market Grows 6.1% in October Against the Trend
On August 21st, an explosion occurred in a pharmaceutical factory in I...
Indian Pharmaceuticals Focus on American Market
Top 10 countries accounted for Indias 63% of Ayush herbal products exp...
Indias bulk drug imports grow 4.12% in 2023-24, imports from China acc...
What are the changes in the export of domestic pharmaceutical intermed...
Indian API industry: Current trends future ahead
India’s mental healthcare grapples with stigma, inadequate resources &...
Indias Quest for Pharma Self-Sufficiency: Reducing Dependence on China
Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463
map
